Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PCSK9 Patent Case: Praluent Injunction Vacated, But May Well Return

Oct 06 2017

• By Sue Sutter

Related Content

Praluent Injunction Goes Unmentioned At PCSK9 Patent Case Appeal

Jun 06 2017

‘Between A Rock And A Hard Place,’ Court Issues Injunction To Halt Praluent Sales

Jan 06 2017

Praluent Lives On As US Court Vacates Amgen's PCSK9 Patent Win

Oct 05 2017

Praluent Fate Uncertain After Amgen Wins PCSK9 Patent Battle

Mar 17 2016

Related Companies

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Additional Topics

United States Intellectual Property Legal Issues Commercial BioPharmaceutical Cardiovascular Metabolic Disorders

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window